# PRIMALung (NCT04790253)

> PRophylactic Cerebral Irradiation or Active MAgnetic Resonance Imaging Surveillance in Small-cell Lung Cancer Patients (PRIMALung Study)

No report yet. It can be ordered.

- Drugs tested: none (the trial tests no drug)
- Indication: small-cell lung cancer

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT04790253
- Phase: NA
- Status: RECRUITING
- Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
- Conditions: Limited Stage Small Cell Lung Cancer; Extensive-stage Small-cell Lung Cancer
- Interventions: Prophylactic cranial irradiation
- Enrollment: 600
- Primary outcome: Overall survival

## Questions raised in the commentary

_Automated from the 38 newest of 45 indexed sources (Jul 2022 – Oct 2026). Each question is raised in at least two. Not an Erudio report: no source links. Not medical advice._

- Whether PCI remains beneficial in the immunotherapy era
- Whether MRI surveillance alone can replace PCI
- How PCI and MRI surveillance compare on survival, cognition, and quality of life

Also discussed: trial recruitment.

## Indexed commentary on PRIMALung so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 34
- Podcasts: 7
- YouTube: 4

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=primalung-nct04790253

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT04790253", "email": "<work email>"}; the inbox owner confirms by the emailed link.